BLAIR JAMES C
Insider CIK 1024000 · ACHN 10% owner · GKOS 10% owner · ALIM 10% owner · MRNS 10% owner · OCRX 10% owner · AKAO 10% owner · RGDO 10% owner · CADX Director, 10% owner · LIFE Director, 10% owner · ALDX 10% owner · CLCD 10% owner · ZGNX Director, 10% owner · VCYT 10% owner · SNDX 10% owner · DRNA 10% owner · EVOK 10% owner · BNGO 10% owner · OBLN 10% owner · ESPR 10% owner · TNDM 10% owner · CLVS Director, 10% owner · OTIC 10% owner · RVA 10% owner · DRTX 10% owner · ATRA 10% owner · NEOT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 42,223 | — | $0 | 42,223 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 40,138 | — | $0 | 40,138 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-20 | 2019-08-20 | 20,000 | $5.97 | $119.4K | 20,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-20 | 20,000 | $5.70 | $114.0K | 33,439 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy deriv | 2019-08-06 | 2019-08-08 | 187,500 | $4.00 | $750.0K | 187,500 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2019-08-06 | 2019-08-08 | 250,000 | $4.00 | $1.00M | 813,433 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 28,882 | — | $0 | 28,882 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-05-08 | 2019-05-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2019-03-18 | 2019-03-18 | 701 | — | $0 | 10,105 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2019-03-18 | 2019-03-18 | 522 | — | $0 | 13,439 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2019-03-18 | 2019-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-14 | 2019-03-18 | 17,056 | $27.79 | $474.0K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2019-02-01 | 2019-02-05 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2019-02-01 | 2019-02-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-10-11 | 2018-10-15 | 14,770 | — | $0 | 14,770 | SEC↗ |
| BNGO BioNano Genomics, Inc | P Buy deriv | 2018-08-23 | 2018-08-27 | 0 | — | $0 | 15,000 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 15,000 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 3,682,919 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 6,396,105 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 5,426,808 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 2,986,762 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 6,810,098 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 0 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 27,328 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 47,460 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 40,268 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 22,161 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion deriv | 2018-08-23 | 2018-08-27 | 50,532 | — | $0 | 0 | SEC↗ |
| BNGO BioNano Genomics, Inc | P Buy | 2018-08-23 | 2018-08-27 | 15,000 | $6.13 | $92.0K | 943,878 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion | 2018-08-23 | 2018-08-27 | 337,694 | $4.59 | $1.55M | 929,878 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion | 2018-08-23 | 2018-08-27 | 591,184 | — | $0 | 591,184 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion | 2018-08-23 | 2018-08-27 | 2,505 | $4.59 | $11.5K | 6,891 | SEC↗ |
| BNGO BioNano Genomics, Inc | C Conversion | 2018-08-23 | 2018-08-27 | 4,386 | — | $0 | 4,386 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2018-08-23 | 2018-08-27 | 1,648,359 | $1.82 | $3.00M | 5,634,329 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2018-05-21 | 2018-05-23 | 32,760 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2018-05-21 | 2018-05-23 | 5,897 | — | $0 | 12,917 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-05-15 | 2018-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2017-12-18 | 2017-12-20 | 49,632 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2017-12-18 | 2017-12-20 | 368 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award | 2017-12-18 | 2017-12-20 | 37,890 | — | $0 | 3,469,029 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2017-12-18 | 2017-12-20 | 1,678,432 | $3.19 | $5.35M | 3,431,139 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award | 2017-12-18 | 2017-12-20 | 282 | — | $0 | 25,730 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2017-12-18 | 2017-12-20 | 12,444 | $3.19 | $39.7K | 25,448 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-13 | 20,150 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-13 | 20,150 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 988,285 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 7,333 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 1,857,036 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 15,731 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 47,963 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-08-16 | 2017-08-18 | 4,835 | — | $0 | 7,020 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-08-16 | 2017-08-18 | 6,477 | — | $0 | 9,404 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-08-16 | 2017-08-18 | 92,518 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-08-04 | 2017-08-08 | 18,450 | $78.61 | $1.45M | 17,056 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-06-23 | 2017-06-27 | 286,857 | — | $0 | 1,000,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-06-23 | 2017-06-27 | 2,869 | — | $0 | 92,518 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy deriv | 2017-04-11 | 2017-04-12 | 49,632 | $100.00 | $4.96M | 49,632 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy deriv | 2017-04-11 | 2017-04-12 | 368 | $100.00 | $36.8K | 368 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-04 | 1,071 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-04 | 17,695 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-04 | 1,996 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 285,679 | $28.35 | $8.10M | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 47,613 | $28.35 | $1.35M | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 3,553,322 | $28.35 | $100.74M | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 1,657 | $28.35 | $47.0K | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-04 | 38,094 | $28.35 | $1.08M | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 597,207 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 1,206,836 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 482,326 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 649,835 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 836,722 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 20,583 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 14,271 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 11,083 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion | 2016-10-12 | 2016-10-14 | 3,985,970 | — | $0 | 3,985,970 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion | 2016-10-12 | 2016-10-14 | 49,570 | — | $0 | 49,570 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | J Other | 2016-09-09 | 2016-09-13 | 1,943,109 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-03 | 2016-08-03 | 81,094 | $8.15 | $660.9K | 1,943,109 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-03 | 2016-08-03 | 129 | $8.15 | $1.1K | 3,039 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-02 | 2016-08-03 | 19,718 | $8.71 | $171.7K | 2,024,203 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-02 | 2016-08-03 | 32 | $8.71 | $279 | 3,168 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-01 | 2016-08-03 | 52,216 | $8.82 | $460.5K | 2,043,921 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-01 | 2016-08-03 | 84 | $8.82 | $741 | 3,200 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-06-09 | 2016-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-05-26 | 2016-05-27 | 344,120 | $4.70 | $1.62M | 606,283 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-05-26 | 2016-05-27 | 5,880 | $4.70 | $27.6K | 10,328 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-05-24 | 2016-05-26 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-04-28 | 2016-05-02 | 235 | $6.96 | $1.6K | 3,284 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-04-28 | 2016-05-02 | 149,765 | $6.96 | $1.04M | 2,096,137 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-27 | 2016-04-27 | 3,603 | $5.02 | $18.1K | 950,403 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-27 | 2016-04-27 | 61 | $5.02 | $306 | 16,208 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-25 | 2016-04-27 | 1,492 | $5.20 | $7.8K | 954,006 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-25 | 2016-04-27 | 21 | $5.20 | $109 | 16,269 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-20 | 2016-04-21 | 4,424 | $5.29 | $23.4K | 955,498 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-20 | 2016-04-21 | 76 | $5.29 | $402 | 16,290 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-19 | 2016-04-21 | 37,054 | $5.36 | $198.6K | 959,922 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-19 | 2016-04-21 | 632 | $5.36 | $3.4K | 16,366 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-11 | 2016-04-13 | 4,348 | $5.22 | $22.7K | 996,976 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-11 | 2016-04-13 | 75 | $5.22 | $392 | 16,998 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-08 | 2016-04-08 | 14,554 | $5.35 | $77.9K | 1,001,324 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-08 | 2016-04-08 | 251 | $5.35 | $1.3K | 17,073 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-07 | 2016-04-08 | 27,781 | $5.26 | $146.1K | 1,015,878 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-07 | 2016-04-08 | 475 | $5.26 | $2.5K | 17,324 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-06 | 2016-04-08 | 8,669 | $5.22 | $45.3K | 1,043,659 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-06 | 2016-04-08 | 148 | $5.22 | $773 | 17,799 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 400,422 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 360,640 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 2,674 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 2,967 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 444,460 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 1,299,394 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 13,925 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 761,062 | — | $0 | 761,062 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 5,641 | — | $0 | 5,641 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 1,743,854 | — | $0 | 1,743,854 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 13,925 | — | $0 | 13,925 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 19,428 | — | $0 | 19,428 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-09-22 | 2015-09-24 | 794,888 | — | $0 | 1,286,857 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-08-18 | 2015-08-20 | 11,836 | $7.02 | $83.1K | 1,052,328 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-08-18 | 2015-08-20 | 202 | $7.02 | $1.4K | 17,947 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-07-16 | 2017-05-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-07-16 | 2017-05-23 | 2,185 | — | $0 | 2,185 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-07-16 | 2017-05-23 | 41,813 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-07-16 | 2015-07-17 | 41,813 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-07-16 | 2015-07-17 | 2,185 | — | $0 | 2,185 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-07-08 | 2015-07-10 | 6,286 | — | $0 | 6,286 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 14,041 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 105,128 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 440,178 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-07-01 | 20,470 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 585,958 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 925,926 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 4,371 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 2,130 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 589,100 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-07-01 | 286,983 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 14,041 | — | $0 | 14,041 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 2,057,190 | — | $0 | 2,057,190 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-07-01 | 8,700 | $18.00 | $156.6K | 2,068,960 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-07-01 | 20,470 | $7.65 | $156.6K | 2,077,660 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 6,501 | — | $0 | 6,501 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-07-01 | 876,083 | — | $0 | 876,083 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-06-11 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 1,506,901 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 12,143,933 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 887,073 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 90,110 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 11,182 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-12 | 6,581 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-12 | 1,807,820 | — | $0 | 1,807,820 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-12 | 13,414 | — | $0 | 13,414 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 464,756 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 939,289 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 798,188 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,954 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,565 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-11 | 2,202,233 | — | $0 | 2,245,902 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-11 | 3,519 | — | $0 | 3,519 | SEC↗ |
| TBRA Regado Biosciences Inc | P Buy | 2015-05-04 | 2015-05-06 | 277,777 | $10.62 | $2.95M | 3,553,322 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | J Other | 2015-05-04 | 2015-05-06 | 36,187 | — | $0 | 38,094 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-16 | 2015-04-16 | 554 | $7.07 | $3.9K | 18,149 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-16 | 2015-04-16 | 32,411 | $7.07 | $229.1K | 1,064,164 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-15 | 2015-04-16 | 135 | $7.58 | $1.0K | 18,703 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-15 | 2015-04-16 | 7,920 | $7.58 | $60.0K | 1,096,575 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-14 | 2015-04-16 | 168 | $7.78 | $1.3K | 18,838 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-14 | 2015-04-16 | 9,832 | $7.78 | $76.5K | 1,104,495 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2015-03-20 | 2015-03-24 | 350,000 | — | $0 | 2,216,935 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-03-05 | 2015-03-05 | 8,528 | $77.70 | $662.6K | 35,506 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-03-03 | 2015-03-05 | 500,000 | — | $0 | 2,081,745 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 2,164,305 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 6,111,968 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 737,422 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 7,252,144 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 92,105 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 165,790 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 2,827 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 12,578 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 104,247 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 36,913 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 102,282 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 1,570 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 7,252,144 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 2,164,305 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 6,111,968 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 737,422 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 165,790 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 92,105 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 1,570 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 2,827 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 102,282 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 36,913 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 104,247 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 12,578 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 165,790 | $8.54 | $1.42M | 3,122,774 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-26 | 2,921,064 | — | $0 | 2,921,064 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 92,105 | $8.54 | $786.6K | 3,013,169 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-11-26 | 70,000 | $14.00 | $980.0K | 3,091,642 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 101,132 | $14.00 | $1.42M | 3,021,642 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 56,185 | $14.00 | $786.6K | 2,956,984 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-26 | 46,309 | — | $0 | 46,309 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 958 | $14.00 | $13.4K | 46,921 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 2,827 | $8.54 | $24.1K | 49,748 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 1,725 | $14.00 | $24.1K | 48,023 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 1,570 | $8.54 | $13.4K | 47,879 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 56,185 | $14.00 | $786.6K | 2,956,985 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 165,790 | $8.54 | $1.42M | 3,122,775 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 101,132 | $14.00 | $1.42M | 3,021,643 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-12-10 | 70,000 | $14.00 | $980.0K | 3,091,643 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-12-10 | 2,921,065 | — | $0 | 2,921,065 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 92,105 | $8.54 | $786.6K | 3,013,170 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 958 | $14.00 | $13.4K | 46,923 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-12-10 | 46,311 | — | $0 | 46,311 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 1,725 | $14.00 | $24.1K | 48,025 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 2,827 | $8.54 | $24.1K | 49,750 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 1,570 | $8.54 | $13.4K | 47,881 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 6,250 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 22,306 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 3,006,132 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 620,776 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 1,272,607 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 9,443 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-21 | 4,606 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-21 | 1,893,383 | — | $0 | 1,893,383 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 248,159 | $11.00 | $2.73M | 2,141,542 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-21 | 14,049 | — | $0 | 14,049 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 1,841 | $11.00 | $20.3K | 15,890 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 500,000 | $20.00 | $10.00M | 2,566,935 | SEC↗ |
| VCYT VERACYTE, INC. | J Other | 2014-09-10 | 2014-09-12 | 300,000 | — | $0 | 2,763,294 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h deriv | 2014-08-18 | 2014-08-18 | 186,828 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise deriv | 2014-08-18 | 2014-08-18 | 67,755 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 925,479 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 436,485 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 3,238 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-18 | 6,866 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise deriv | 2014-08-18 | 2014-08-18 | 502 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h deriv | 2014-08-18 | 2014-08-18 | 1,386 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h | 2014-08-18 | 2014-08-18 | 37,224 | $16.00 | $595.6K | 1,579,323 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise | 2014-08-18 | 2014-08-18 | 67,755 | $8.79 | $595.6K | 1,616,547 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-18 | 1,548,792 | — | $0 | 1,548,792 | SEC↗ |
| OTIC Otonomy, Inc. | F Tax w/h | 2014-08-18 | 2014-08-18 | 277 | $16.00 | $4.4K | 11,715 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-18 | 11,490 | — | $0 | 11,490 | SEC↗ |
| OTIC Otonomy, Inc. | M Exercise | 2014-08-18 | 2014-08-18 | 502 | $8.79 | $4.4K | 11,992 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 579,630 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 820,320 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 657,192 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 8,792 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 1,165 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 7,043 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 2,057,142 | — | $0 | 2,057,142 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 419,744 | $8.00 | $3.36M | 2,476,886 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-06-12 | 2014-06-19 | 12,414 | — | $0 | 12,414 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2014-05-21 | 2014-05-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-07 | 2014-05-07 | 0 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-07 | 2014-05-07 | 21,250 | — | $0 | 1,973,389 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 60,576 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 60,576 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 755,263 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 486,316 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 3,882 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 60,576 | $5.16 | $312.6K | 1,969,689 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 39,063 | $8.00 | $312.5K | 1,930,626 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 60,576 | $5.16 | $312.6K | 1,991,202 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 1,909,113 | — | $0 | 1,909,113 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 39,063 | $8.00 | $312.5K | 1,952,139 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 9,208 | — | $0 | 9,208 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 25,000 | $6.79 | $169.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $1.70 | $21.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $7.65 | $95.6K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $4.63 | $57.9K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $6.84 | $85.5K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 17,500 | $11.02 | $192.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $4.75 | $59.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 7,313,241 | $14.00 | $102.39M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 78,369 | $14.00 | $1.10M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 27,500 | $14.00 | $385.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 50,743 | $14.00 | $710.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 2,972,678 | $14.00 | $41.62M | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 625,065 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 15,799 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 10,661 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 7,430 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 435,663 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 926,321 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion | 2014-03-17 | 2014-03-17 | 1,987,049 | — | $0 | 1,987,049 | SEC↗ |
| AKAO Achaogen Inc | C Conversion | 2014-03-17 | 2014-03-17 | 33,890 | — | $0 | 33,890 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-14 | 23,317 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,367,020 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-14 | 13,058 | $14.00 | $182.8K | 50,743 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-14 | 23,317 | $7.84 | $182.8K | 63,801 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-14 | 765,532 | $14.00 | $10.72M | 2,972,678 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-14 | 1,367,020 | $7.84 | $10.72M | 3,738,210 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 3,535 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 21,041 | — | $0 | 21,041 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 21,041 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 1,276,243 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 476,464 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 9,469 | — | $0 | 0 | SEC↗ |